Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Prevalence of malnutrition and 12-month incidence of mortality in two Sydney teaching hospitals.

Middleton MH, Nazarenko G, Nivison-Smith I, Smerdely P.

Intern Med J. 2001 Nov;31(8):455-61.

PMID:
11720058
2.

Human keratinocytes maintain reversible anti-apoptotic defenses in vivo and in vitro.

Norris DA, Middleton MH, Whang K, Schleicher M, McGovern T, Bennion SD, David-Bajar K, Davis D, Duke RC.

Apoptosis. 1997;2(2):136-48.

PMID:
14646548
3.

Staphylococcal toxins and protein A differentially induce cytotoxicity and release of tumor necrosis factor-alpha from human keratinocytes.

Ezepchuk YV, Leung DY, Middleton MH, Bina P, Reiser R, Norris DA.

J Invest Dermatol. 1996 Oct;107(4):603-9.

4.

Expression of E and P-cadherin by melanoma cells decreases in progressive melanomas and following ultraviolet radiation.

Seline PC, Norris DA, Horikawa T, Fujita M, Middleton MH, Morelli JG.

J Invest Dermatol. 1996 Jun;106(6):1320-4.

5.

In three types of interface dermatitis, different patterns of expression of intercellular adhesion molecule-1 (ICAM-1) indicate different triggers of disease.

Bennion SD, Middleton MH, David-Bajar KM, Brice S, Norris DA.

J Invest Dermatol. 1995 Jul;105(1 Suppl):71S-79S.

6.
7.
8.

Inhibition of antibody formation by receptor cross-linking: the molecular characteristics of inhibitory haptenated polymers.

Dintzis RZ, Okajima M, Middleton MH, Dintzis HM.

Eur J Immunol. 1990 Jan;20(1):229-32.

PMID:
1689663
9.

The immunogenicity of soluble haptenated polymers is determined by molecular mass and hapten valence.

Dintzis RZ, Okajima M, Middleton MH, Greene G, Dintzis HM.

J Immunol. 1989 Aug 15;143(4):1239-44.

PMID:
2473123
10.

Recombinant mouse interferon-gamma is not chemotactic for macrophages or neutrophils.

Canono BP, Middleton MH, Campbell PA.

J Interferon Res. 1989 Feb;9(1):79-86.

PMID:
2497200
11.

Tolerogen-mediated suppression of the immune response. Suppressor cells as passive transfer agents.

Dintzis RZ, Middleton MH, Dintzis HM.

Scand J Immunol. 1988 Dec;28(6):747-57.

PMID:
2976522
12.
13.

Studies on the immunogenicity and tolerogenicity of T-independent antigens.

Dintzis RZ, Middleton MH, Dintzis HM.

J Immunol. 1983 Nov;131(5):2196-203.

PMID:
6631009
14.
15.

A participatory planning process for the evaluation of community mental health centers.

Faulkner LR, Cutler DL, Middleton MH.

Community Ment Health J. 1982 Fall;18(3):169-79. No abstract available.

PMID:
7172613

Supplemental Content

Loading ...
Support Center